COVID-19 New Cases at 711 Despite Weekend Effect... Highest Monday Count Since 3rd Wave

On the 4th, citizens who visited the temporary screening clinic set up at Seoul Station Plaza are lining up to get tested. Photo by Jinhyung Kang aymsdream@

[Asia Economy Reporter Lee Chun-hee] Despite the 'weekend effect' such as a decrease in the number of tests, the number of new domestic COVID-19 confirmed cases remained above 700 for three consecutive days.

The Korea Disease Control and Prevention Agency Central Disease Control Headquarters (CDCH) announced that as of midnight on the 5th, the cumulative number of COVID-19 confirmed cases increased by 711 from the previous day to 160,795. The infection routes of the new confirmed cases were 644 local transmissions and 67 imported cases.

About 82% of the locally transmitted confirmed cases occurred in the Seoul metropolitan area. There were 301 cases (46.7%) in Seoul, 210 cases (32.6%) in Gyeonggi, and 16 cases (2.5%) in Incheon, totaling 527 confirmed cases in the metropolitan area.

In other regions, confirmed cases were reported as follows: 20 in Busan, 20 in Gyeongnam, 18 in Daejeon, 10 in Chungnam, 10 in Gyeongbuk, 7 in Gangwon, 6 in Gwangju, 6 in Jeonbuk, 5 in Jeju, 4 in Daegu, 4 in Sejong, 3 in Chungbuk, 3 in Jeonnam, and 1 in Ulsan.

There were 67 imported confirmed cases. Among them, 25 were detected during quarantine, and 42 were confirmed locally. There were 40 Korean nationals and 27 foreigners.

The total number of tests conducted the previous day was 32,216. At temporary screening clinics set up in the metropolitan area, 15,938 tests were conducted, confirming 131 new cases, while 1,269 tests were conducted at temporary screening clinics outside the metropolitan area, confirming 2 new cases.

On the morning of the 30th of last month, a citizen is receiving the Pfizer vaccine at the vaccination center in Yongsan-gu, Seoul. [Image source=Yonhap News]

Meanwhile, there were no new COVID-19 vaccinations as of midnight on the same day. The cumulative number of vaccinated people was 15,347,214, with a vaccination rate of 29.9% of the population.

The number of people who completed vaccination increased by 625 from the previous day to 5,321,602. The vaccination rate for the second dose was 10.4% of the population. An additional 625 people received the Pfizer vaccine, bringing the total number of completed vaccinations to 3,222,189. There were no additional vaccinations for AstraZeneca (AZ). Moderna’s additional vaccination interval has not yet arrived, and the Janssen vaccine was developed for the first dose only, so all first-dose recipients are included among those who completed vaccination.

Reports of suspected adverse reactions after vaccination increased by 829 cases over two days, totaling 95,378 cases. Reports included 502 cases for AZ, 239 for Pfizer, 74 for Janssen, and 14 for Moderna. The cumulative adverse reaction reporting rates were 0.63% for AZ, 0.24% for Pfizer, 0.60% for Janssen, and 0.47% for Moderna.

Among the new reports, 790 cases were common post-vaccination symptoms such as muscle pain, headache, fever, chills, and nausea, accounting for the majority.

Serious adverse reactions included 1 suspected case of anaphylaxis and 36 additional reports of major neurological adverse reactions. Two deaths following vaccination were reported: one after receiving the AZ vaccine and one after receiving the Pfizer vaccine.

This content was produced with the assistance of AI translation services.